Inventor · disambiguated record
Yijuang Chern
Also filed as: CHERN YIJUANG
7 granted patents·4 pending applications·25 citations·filing 2003–2023
79Inventor score
Top patents by PatentIndex Score
11 records- 0185US7351434B2Therapeutic Gastrodia extractsACADEMIA SINICA·Filed 2006·Granted Apr 1, 2008·13 cites·5 claims
- 0281US8129357B2Method of making and using an adenosine analogueCHERN YIJUANG·Filed 2007·Granted Mar 6, 2012·7 cites·4 claims
- 0371US7220729B2Huntington's Disease TreatmentACADEMIA SINICA·Filed 2004·Granted May 22, 2007·5 cites·7 claims
- 0463US2025360155A1Method of treating spinal cord injury and composition for use thereinACADEMIA SINICA·Filed 2023·Application pending·0 cites
- 0551US10117890B2Methods and compositions for treating painACADEMIA SINICA·Filed 2016·Granted Nov 6, 2018·0 cites·8 claims
- 0649US10301348B2Compounds for use in prevention and treatment of neurodegenerative diseases and painACADEMIA SINICA·Filed 2014·Granted May 28, 2019·0 cites·20 claims
- 0748US10342818B2Dual-action compounds targeting adenosine A2A receptor and adenosine transporter for prevention and treatment of neurodegenerative diseasesACADEMIA SINICA·Filed 2015·Granted Jul 9, 2019·0 cites·4 claims
- 0848US2015038445A1Methods and compositions for treating painACADEMIA SINICA·Filed 2013·Application pending·0 cites
- 0940US10882890B2Bipartite molecules and uses thereof in treating diseases associated with abnormal protein aggregatesACADEMIA SINICA·Filed 2015·Granted Jan 5, 2021·0 cites·4 claims
- 1039US2012295863A1Dual-Action Compounds Targeting Adenosine A2A Receptor and Adenosine Transporter for Prevention and Treatment of Neurodegenerative DiseasesLIN YUN-LIAN·Filed 2010·Application pending·0 cites
- 1137US2004229837A1Treatment of neurodegenerative diseasesFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yijuang Chern files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →